HR 2620 · 116th Congress 2019โ€“2021, ended

Faster Treatments and Cures for Eye Diseases Act

Latest action · May 10, 2019 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMay 9, 2019
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Faster Treatments and Cures for Eye Diseases Act

This bill requires the Department of Health and Human Services to establish a pilot program that provides for a partial federal guarantee of specified bonds, the sale of which shall finance promising translational vision-impairment research with private investment. The Government Accountability Office must study this program and consider whether similar programs should be established for other areas of biomedical research.

Cosponsors 21

Members who signed on, in the order they did. Signatures ran from May 9, 2019 to Jul 20, 2020; 6 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-ILBradley Scott SchneiderOriginalMay 9, 2019
R-PABrian K. FitzpatrickOriginalMay 9, 2019
R-WACathy McMorris RodgersOriginalMay 9, 2019
R-FLGus M. BilirakisOriginalMay 9, 2019
D-TNSteve CohenOriginalMay 9, 2019
D-AZTom O'HalleranOriginalMay 9, 2019
R-TXKenny MarchantMay 14, 2019
D-NYEliot L. EngelMay 22, 2019
R-TXPete OlsonMay 22, 2019
D-FLDebbie Wasserman SchultzJun 12, 2019
D-NCG. K. ButterfieldJul 9, 2019
R-NEJeff FortenberryJul 9, 2019
D-FLDarren SotoJul 10, 2019
D-CAJared HuffmanAug 9, 2019
R-FLJohn H. RutherfordAug 9, 2019
D-ILBobby L. RushAug 30, 2019
D-GAHenry C. "Hank" Johnson, Jr.Aug 30, 2019
R-MITim WalbergAug 30, 2019
D-ALTerri A. SewellOct 29, 2019
D-CAMike LevinFeb 11, 2020
D-NYGregory W. MeeksJul 20, 2020

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred May 9, 2019
Health Subcommittee
Referred May 10, 2019

Actions 3

Everything that happened, newest first.

  1. May 10, 2019Referred to the Subcommittee on Health.
  2. May 9, 2019Introduced in House
  3. May 9, 2019Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: The Commerce Clause, Article 1, Section 8, Clause 3

The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 77, May 9, 2019, page H3680.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To advance treatment and cures for blindness and other retinal conditions and to promote competitiveness in the United States through a pilot program to increase funding for translational research, and for other purposes.
Short Title(s) as Introduced
Faster Treatments and Cures for Eye Diseases Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. May 9, 2019Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.